Collaboration with industry
Collaborations between academia and industry are becoming increasingly important and SciLifeLab Stockholm is working actively to find new forms of collaboration with national and international industry partners. These collaborations have large potential for societal gains in a wide range of applications. Examples range from a faster route to convert new knowledge into products or therapies in medicine and health care to new ways to produce biofuels.
Based on the advanced technologies and instrumentation available, SciLifeLab Stockholm aims to be involved in the development of new techniques and instrumentation in collaboration with industry and to be a reliable and competent partner for development and testing of new technology. Several such collaborations are ongoing at SciLifeLab Stockholm. Another interesting possibility for industrial collaboration is to get smaller companies to use the resources at SciLifeLab as means for increasing their international competitiveness. This will be based on a full-cost policy, but might still be attractive for some companies. Finally, SciLifeLab Stockholm is an attractive partner for pharmaceutical industry in larger scientific studies. One interesting possibility here is to use the infrastructure built up in SciLifeLab along with Sweden’s unique clinical materials and skills to promote Sweden as a location for research on the major international pharmaceutical companies.
research program has also been established for collaborations between AstraZeneca and SciLifeLab associated groups. Example of collaboration: GE Healthcare
The GE Healthcare DemoLab is a facility equipped with GE Healthcare’s instrumentation and reagents for life science research. This complements the instrumentation and competence provided by SciLifeLab and facilitates collaboration between industry and academia. The instrumentation includes ÄKTA for purification and analysis of biomolecules, Biacore and MicroCal technology for biomolecular interaction analysis and the imaging systems Image Quant and Typhoon, and IN Cell Analyzer. During 2012, GE DemoLab has been carrying out a large number of projects together with research groups in the Stockholm-Uppsala region.
In June 2012, AstraZeneca started up the Translational Science Centre in collaboration with Karolinska Institutet. The center is situated at SciLifeLab Stockholm and will be focusing on finding biomarkers for different chronic diseases, such as cancer, rheumatoid arthritis, cardiovascular disease and dementia. A joint collaborative open
Photo: Staffan Eliasson
Example of collaboration: AstraZeneca
GE Healthcare DemoLab.
SciLifeLab Stockholm Annual report 2012 | 23